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ABSTRACT 
 
Purpose of the review. Psychological distress and mental health comorbidity are common in 
cancer. Various therapeutic frameworks have been used for interventions to improve 
psychological wellbeing and quality of life in cancer patients with mixed results. This paper 
reviews contributions to that literature published since January 2017. 
 
Recent findings. The majority of new psychological intervention research in cancer has used 
Cognitive Behavioural Therapy or Mindfulness-Based Interventions. Cognitive behavioural 
Therapy has been considered a gold-standard intervention and recent evidence justifies 
continuation of this. Recent reviews call into question the validity of evidence for Mindfulness-
Based Interventions. A smaller number of trials using Acceptance and Commitment Therapy, 
Meta-Cognitive Therapy, Dignity Therapy and Coaching have emerged, and whilst findings are 
promising, additional fully-powered trials are required. Weaker evidence exists for counselling, 
support-based, and Narrative Therapy interventions. 
 
Summary. Efficacious, timely and acceptable psychological interventions are a necessary 
component of comprehensive cancer care. There is some way to go before the evidence 
conclusively points towards which interventions work for which cancer groups and for which 
specific outcomes. Methodological limitations must be addressed in future trials; at the forefront 
remains the need for fully-powered, head-to-head comparison trials. 
 
Keywords: Cancer, Psychological Distress, Psychological Intervention, Cognitive Behavioural 
Therapy, Third-Wave Therapies 
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INTRODUCTION 
 
Regardless of diagnosis or prognosis, the challenges that cancer brings present risk to 
psychological wellbeing, and the need for psychological support is well-established. Population 
estimates of clinical psychopathology vary between clinical and sociodemographic groups making 
it almost impossible to provide definitive summary incidence. For example, depression 
prevalence ranges from 4-49% in published work [1]. Anxiety is also common [2], alongside 
adjustment [3] and post-traumatic stress [4] disorders, and cancer groups are at higher relative risk 
of suicide compared to general populations [5*]. Furthermore, new diagnostic categories are 
emerging including clinically-relevant fear of cancer recurrence (FCR) [6], though how this 
disambiguates from clinical anxiety remains unclear. Non-clinical emotional distress is observed in 
up to 75% of cancer patients [7,8**]. Consequently, routine distress screening [9] and holistic 
needs assessment [10] are recommended. Comprehensive care — including evaluation, referral 
and follow-up — is essential for distress management [11]. 
 
An array of therapeutic modalities has explored how best to support cancer patients’ 
psychological needs, including individualised, group-based, and online, self-administered 
interventions. Early suggestions of survival benefits failed to replicate and had largely been 
discredited, but a recently published pooled analysis (n=163,363) concluded that ‘psychological 
distress might have some predictive capacity for selected cancer presentations…’ ( p.1) [12**]. 
Survival aside, evidence syntheses suggest psychological interventions have clear and beneficial 
effects for anxiety, depression and quality of life (QoL) [13,14], in the short-term at least. 
 
In this paper we review recent additions to this literature (2017 onwards). We structure this around 
three groupings of psychological interventions, as informed by broader psychological literature: 
 
1. Cognitive Behavioural Therapy (CBT). Perhaps the most well-known intervention 
framework, CBT is the current gold-standard treatment. Content varies based on 
symptoms targeted, but typically includes: psychoeducation; cognitive strategies to 
challenge unhelpful beliefs (cognitive restructuring, core belief work); and, behavioural 
strategies to challenge avoidance behaviours (behavioural activation, exposure) [15]. 
  
2. Third-wave interventions. Often considered an evolution of traditional CBT [16], many 
therapists use these integratively. Underpinned by contextual behavioural science and 
behaviour analysis more broadly, they focus less on cognitive strategies, giving more 
therapeutic attention to reducing problematic functional consequences of cognitions on 
behaviour. Hulbert-Williams et al [17] outlined third-wave interventions as a promising 
avenue for psychological support in cancer. 
 
3. Other intervention frameworks. Many other frameworks could be used, with some more 
frequently applied to cancer than others. Support groups and supportive expressive 
group (psycho)therapies [18] are widely used, whilst others, such as Narrative Therapy 
[19] and Dignity Therapy [20] are more restricted to palliative cancer settings. Existential 
and meaning-focussed interventions are not reviewed given a recently published review 
[21*]. 
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This paper is not intended to provide a fully systematic review of the available literature as space 
does not permit that. Instead, our review offers an overview of the most pertinent literature on 
this topic. Relevant literature was identified using the Google Scholar database. Although 
sometimes criticized, empirical research has demonstrated the efficacy of Google Scholar for 
comprehensive reviews [22]. We searched literature from January 2017 – April 2018 using the 
following search terms: “cancer” with “cognitive behavioural therapy”, “mindfulness”, 
“acceptance and commitment therapy”, “meta-cognitive”, “support”, “support group”, 
“supportive expressive”, “counselling”, “dignity therapy”, “narrative therapy”, “coaching”, 
“solution focused therapy”, “compassion focused therapy”, and “schema therapy”. 
 
COGNITIVE BEHAVIOURAL THERAPY 
 
34 CBT articles have been published, including: eight systematic/meta-analytic reviews 
[23,24,25*,26,27*,28-30]; two protocol papers [31,32]; two qualitative studies [33,34]; five single-
arm pilot/feasibility/secondary analysis studies [35,36,37*,38,39]; and 17 randomised controlled 
trial (RCT) papers [40,41**,42-44,45*,46-49,50*,51*,52-55] (see table 1). Many newer studies focus 
on adaptations for different delivery modalities to increase reach and accessibility, including both 
online and print-based self-help, and blended approaches where face-to-face therapy is 
supplemented with telephone or online components. While these programs show promise, a 
systematic review of 14 self-guided interventions concluded that evidence was lacking, 
predominantly due to small samples and insufficient power [27*]. Of note, the evidence for those 
screened with high distress was stronger.  
 
[INSERT TABLE 1 HERE] 
 
Face-to-face CBT remains prevalent, but recent trials have explored non-psychologist delivery. 
Turner et al’s [50*] RCT was noteworthy: their brief intervention was delivered predominantly by 
nurses, and though not superior compared to usual care control (UCC), participants with disease 
progression had fewer unmet needs over time. Methodological feasibility was demonstrated, but 
more intensive, or specialist-delivered, interventions may be warranted. Further research on non-
psychologist delivered treatment for distress is recommended elsewhere too [25*].  
 
CBT is adaptable across clinical presentations and recently published trials include tailoring for: 
FCR [45*,51*]; clinically-elevated distress [40]; insomnia [36,39,40,44,48]; sexual dysfunction 
[43,55]; depression and/or anxiety [33,40,41**,47,50*]; fatigue [49]; symptom clusters [35,46]; hot 
flushes [34]; and broader non-specific psychosocial coping [53-55]. Most demonstrate positive 
outcomes, but effect sizes vary considerably, with some comparison trials under-powered to 
detect between group differences. Interventions for FCR—particularly Lichtenthal et al’s [45*] 
AIM-FBCR and van der Wal’s [51*] SWORD trials—were innovative in trialing blended delivery. 
Four papers focussed on internet-facilitated delivery in AYA populations [32,33,37*,38]: these 
trials are smaller and more preliminary in scope, though promising findings are emerging.  
 
CBT trials focus almost exclusively on non-advanced cancer. One notable exception piloted a five-
session positive-affect program for women with metastatic breast cancer (MBC), comparing online 
versus face-to-face delivery against attention control [41**]. The program was feasible and 
acceptable with both online and face-to-face versions reducing depression and negative affect at 
one-month follow-up, with depression falling below minimal clinically meaningful difference 
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(MCMD) thresholds significantly more than controls. Targeting positive affect may have improved 
engagement, something often problematic in metastatic intervention research [56*]. 
 
Xiao et al [28] summarised 13 trials, concluding significant efficacy with large effect sizes for 
individually-delivered CBT for depression following breast cancer surgery. Ye et al [29] meta-
analysed 10 studies, and Matthews et al [26] systematically reviewed 32 studies: both concluded 
clear evidence for CBT in treating anxiety and depression and improving QoL. Contrastingly, 
Zhang et al [30] concluded no evidence of efficacy for stress or QoL, but their included studies 
were heterogeneous, possibly limiting effects. Both Bradford et al [23] and Coughtrey et al [24] 
report modest evidence for psychological improvement in Adult and Young Adolescent (AYA) 
populations, however quality issues are problematic. All reviews agree further adequately-
powered studies are required.  
 
Whilst this evidence is promising, much of it derives from trials under ‘ideal’ conditions. Few 
pragmatic trials have been conducted, and it remains unclear how well CBT works in ‘real world’ 
settings — for example, in patients with complex physical or psychological comorbidities. 
 
THIRD-WAVE PSYCHOLOGICAL INTERVENTIONS 
 
Mindfulness-based interventions (MBIs) 
 
These interventions have been increasingly investigated and recommended in cancer settings. 
Since 2017, two systematic reviews [57**,58*], two protocol papers [59,60], two cross-sectional 
studies [61*,62], one feasibility study [63*], four single-arm trials [64-67], and nine RCTs [68-76] 
have been published (see table 2). Overall, there is little consistency in results, intervention 
content, or outcomes used. Of the nine RCTs, six recruited only women with breast cancer 
[69,71*,72,73,75*,76], and the continued publication of underpowered studies is concerning, 
emphasised by consistent use of waitlist or UCC. One RCT compared MBI against an active 
control [75*].  
 
[INSERT TABLE 2 HERE] 
 
Several papers reported moderation/mediation analyses suggesting psychological mechanisms 
for MBIs, as well as identifying groups who may derive greater benefits. Schellekens et al’s 
[75*] secondary analysis indicated social support increases may moderate improvements in 
mood disturbance and stress. Johannsen et al’s [71] RCT in women reporting persistent pain 
after breast cancer treatment identified attachment avoidance as a statistically significant 
moderator of maximised potential benefit. 
 
Haller et al’s [57**] meta-analysis of 10 MBIs demonstrated post-intervention improvements in 
QoL, fatigue, sleep, stress, anxiety, and depression, but only depression and anxiety 
improvements were significant at six-month, and only anxiety at twelve-month follow-up. 
Studies comparing Mindfulness-Based Stress Reduction (MBSR) with other active interventions 
demonstrated significant differences for anxiety and depression, but average effects were 
typically below MCMD. 
 
Shaw et al’s [58*] systematic review of 30 RCTs found none adhered to standard MBSR 
protocols, with modifications poorly reported and contact time limited. Choice of outcomes 
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were also poorly justified. The authors suggest the terms MBSR, Mindfulness-Based Cognitive 
Therapy (MBCT), and MBI are used as short-hand descriptions even though interventions are 
not comparable in terms of definition, dose, or outcome. More content modification 
justification and exploration of potential mechanisms is needed before embarking on larger 
definitive effectiveness trials. 
 
Acceptance and Commitment Therapy (ACT) 
 
Few ACT trials have been published in cancer settings since the first RCT in 2012 [88]. Small-scale 
investigations report promising effects, but are methodologically limited [89,90] or feasibility 
studies only [91]. Recent additions include: one single-subject design [77*]; one single-arm 
intervention [78*] (described as CBT, we include here because of the focus on experiential 
avoidance as therapeutic process); and, three RCTs [79**,80*,81**] (see table 2). One trial [92] is 
excluded (despite impressive findings) due to concerns about data analytic and reporting quality.   
 
Cederberg et al’s [77*] single-subject design demonstrated improvement in treatment-related 
pain intensity and discomfort in five child/adolescent cancer patients. Aguirre-Camacho et al [78*] 
reported improvements across multiple outcomes, but only change in anxiety met MCMD criteria, 
with experiential avoidance mediating outcome improvement. One RCT compared group-
delivered ACT, Behavioural Activation (BA), and wait-list control [79**]. Given conceptual 
similarity, it is unsurprising neither ACT or BA was superior, however both significantly reduced 
anxiety and depression more than control. A pilot RCT comparing telephone-based ACT and 
education/support control in MBC [80*], demonstrated significantly larger decreases in symptom 
interference (related to fatigue and sleep impairment) but neither this, nor reduced depression, 
significantly differed from control. Urech et al’s [81**] STREAM trial (wait-list RCT of therapist-
guided web-based ACT, including elements of MBSR and CBT) resulted in significant, small-to-
medium effect sizes for distress and QoL, but non-significant improvement in anxiety and 
depression. 
 
One final, non-randomised wait-list control study is noteworthy [82**]. This study reported large 
between-group effects on FCR intensity and interference despite not reducing distress 
significantly. We agree with the authors that this is an ACT-consistent finding: third-wave 
approaches aim not to eliminate distress, but reduce its behavioural impact. Reduced FCR 
interference in the presence of continued distress achieves that aim. 
 
This small interventional evidence-base complements literature correlating ACT therapeutic 
processes and cancer outcomes [93,94] which has recently expanded to include: poorer symptom 
experiences [83]; problematic anxiety, depression and anticipatory grief [85]; and, moderation 
effects between unmet needs and distress [85*].  
 
Meta-Cognitive Therapy (MCT) 
 
Two MCT interventions have been published [86**,87*]. Fisher et al’s [87*] case-series study 
delivered MCT to four patients with emotional distress, reporting clinically significant reductions in 
anxiety, depression and FCR, maintained to six-month follow-up. Butow et al’s [86**] Conquer 
Fear trial was especially innovative: including elements of ACT this trial reported significant 
improvements in both FCR and distress up to six-month follow-up. 
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OTHER INTERVENTION APPROACHES 
 
This section synthesises the evidence for a range of less-researched interventions (see table 3). 
 
Support Groups, Supportive Expressive Therapy and Counselling 
 
A Cochrane Review of six online support group interventions in women with breast cancer 
concluded low quality and mixed results provide insufficient evidence supporting their use in this 
context [95**]. Two single-arm designs [96,97] and three RCTs [98,99,100] reporting 
psychoeducation, online support groups, supportive-expressive group therapy, or combinations 
thereof concur. 
 
[INSERT TABLE 3 HERE] 
 
Two single-arm studies [101,102] and two RCTs [103*,104*] explored supportive, psychological or 
interpersonal counselling either in isolation or part of complex interventions. Four additional 
cross-sectional studies investigated relationships between use of psychosocial support services 
and psychological outcomes [105,106], treatment decision-making [107], and online community 
engagement [108]. This body of work is variable making it difficult to detect consistent patterns in 
outcomes. Many studies lack theoretical underpinning for intervention content, and small 
samples, inclusion of non-clinical samples, multiple endpoints, and inappropriate analyses 
potentially dilute effects.  
 
Three studies report qualitative and/or feasibility designs [109-111] and initial efficacy indicators 
suggest several interventions worthy of additional investigation. 
 
Dignity and Narrative Therapies 
 
Dignity Therapy is used primarily in advanced cancer. Martínez et al’s [112**] systematic review of 
28 studies concluded overall benefit, however, only one RCT (of five) demonstrated significant 
decreases in anxiety and depression over time. The remaining RCTs were inconclusive, but other 
benefits included improved end-of-life experiences. One protocol paper for a culturally-adapted 
intervention [113] was published. Two qualitative studies [114,115] emphasise the importance of 
life review and creation of ‘legacy document’ components of Dignity Therapy. Dose et al’s [116*] 
pilot trial demonstrated feasibility and acceptability for delivery in outpatient clinics, and Julião et 
al’s [117**] RCT demonstrated statistically significant reductions in demoralisation and desire for 
death against UCC. Although Vuksanovic et al’s [118*] RCT demonstrated positive effects on 
generativity, meaning and acceptance, no significant changes in distress or QoL were reported in 
either the intervention or life review/waitlist control groups. 
 
Two Narrative Therapy interventions have been published. Lloyd-Williams et al’s [119*] pilot RCT 
(compared with UCC) in patients with advanced cancer demonstrated greater reduction in 
depression and longer median survival, though differences were not significant. Similarly, Wise et 
al’s [120**] RCT for Stage III/IV cancer patients also failed to identify significant effects on anxiety 
or depression.  
 
Coaching-based approaches 
 
MS# SPC1203B   
 
Coaching differs from therapy in that interventions are briefer, problem-focussed, and targeted at 
improving wellbeing in non-clinical populations. Coaching is being used with increased frequency 
to support health behaviour change [123] and improve healthcare communication [124]. One 
recent RCT trained cancer survivors as peer-facilitators of coaching [121**]; results indicated 
significantly reduced anxiety compared to UCC, but non-significant effects on depression and 
QoL. Lay coaches were also used in McCusker et al’s [122*] trial for depression. Eight weekly, 
telephone-delivered sessions were received, and although depression significantly decreased, 
there was no control group comparator. A programme of work based on the FORECAST web-
based coaching framework is underway [125]. The high prevalence of non-clinical cancer-related 
distress may indicate coaching as an appropriate and effective modality, especially as moving 
away from ‘therapy’ might reduce stigma associated with psychological help seeking [126]. We 
encourage research exploring theory-driven coaching interventions, such as Cognitive Behavioural 
and Contextual Behavioural Coaching [127,128]. 
 
CONCLUSIONS 
 
There is continued dominance of CBT. Within these studies, non-psychologist and alternative 
modality delivery is emerging, especially in AYA populations, and is important to overcoming 
psychosocial oncology workforce and access issues. Recent research highlights concerns 
regarding MBIs. ACT and MCT show promising effects, but additional appropriately-powered 
trials are needed. Dignity Therapy continues to show reasonably strong evidence in advanced 
cancer, though the literature is small. Counselling, supportive expressive approaches, and 
Narrative Therapy demonstrate weakest evidence to date. The emergence of coaching-based 
interventions is encouraging, but transition towards evidence-based coaching frameworks its 
recommended. We were unable to identify recent trials using Solution Focussed Therapy [129], 
Compassion Focussed Therapy [130] or Schema Therapy [131] despite growing evidence bases 
outside cancer. 
 
There are common methodological limitations which future trials should address: 
 
1. An excess of small-scale, feasibility and single-arm designs continues. Fully powered 
trials, including active controls, and head-to-head comparisons are needed. A lack of 
pragmatic and implementation trials limits knowledge of how successfully these might be 
integrated into routine clinical care. 
 
2. Most research tests one-size-fits-all interventions. Unsurprisingly, therefore, significant 
effects are typically reported in only participants high in baseline distress. Testing of 
stepped-care models, and interventions tailored to specific population needs (e.g. low 
literacy) is currently neglected. 
 
3. Trials in advanced, non-breast cancer, and non-adult samples are emerging though 
expansion of this evidence-base is needed. Though trials are emerging from non-
anglophone countries, these are often poorer quality in design and reporting, highlighting 
broader capacity and training needs. 
 
4. Few studies assess moderators/mediators of intervention outcomes, a major omission 
particularly as second- and third-wave interventions become less distinct. The emphasis in 
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clinical psychology away from package- and towards process-based interventions [132**] 
must occur in psychosocial oncology too. 
 
5. Trial outcomes should be chosen from a theoretical basis and it is rarely appropriate to 
include only distress reduction. Inclusion of health economic/utilisation data may provide 
powerful data for commissioners of clinical services. Authors should be more honest in 
reporting intervention outcomes: trials often assess multiple outcomes, many resulting in 
null-findings. An over-simplified and perhaps too positive message is often being 
disseminated.  
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KEYPOINTS 
 
• There is a clear need for psychological support for cancer patients, and having efficacious, 
timely and accessible interventions is key to effective distress management. 
• A number of new intervention studies have been published, the majority using Cognitive 
Behavioural Therapy, although growth is occurring in Acceptance and Commitment Therapy, 
Meta-Cognitive Therapy and Dignity Therapy.  
• Cognitive Behavioural Therapy remains the gold-standard and most empirically supported 
intervention framework, although this may partly be by default: other interventions 
approaches do not yet have equivalence in terms of research funding and trial numbers. 
• The recent evidence base for Narrative Therapy, Supportive Expressive Therapies, 
Counselling, and Mindfulness Based Interventions raises concerns. 
• Future research needs to improve on methodological limitations if a conclusive and persuasive 
evidence base is to develop for implementation of psychological interventions in cancer care. 
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Study 
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Summary 
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n/a Moderate-to-strong pooled effects of CBT on QOL, 
depression, stress, anxiety, hyperarousal. 
30 Zhang, Huang, 
Feng, et al. 
(2017) 
China Breast Cancer 
survivors 
6 studies Meta-analytic 
review 
n/a Examined impact of CBT on QOL and stress; no 
impact found for breast cancer survivors. But: only 6 
studies included and all underpowereded; CBT often 
delivered in combination with other treatments 
(exercise, hypnosis etc).  
31 Murphy, 
Newby, Butow, 
et al. (2017) 
Australia Heterogeneous 
Cancer Survivors 
n/a RCT - 
Protocol 
Usual care RCT Protocol of an internet-delivered 
transdiagnostic supervised program (iCanAdapt-
Early) for diagnosed depression and/or anxiety in 
early stage cancer survivors. 
32 Ander, 
Wikman, 
Ljotsson, et al. 
(2017) 
Sweden AYA (ages 15-25) Aim N=30 Single arm 
feasibility – 
protocol 
n/a  Protocol of an uncontrolled feasibility trial, pre-post, 
3-month follow-up design. Participants will receive 
YoungCan – therapist guided, internet-administered 
self-help CBT.  
  
33 Ander, 
Woodford, 
Cernvall, et al. 
(2017) 
Sweden AYA (ages 17-25) N=10 Single arm n/a Individual CBT (up to 15 sessions); clinical outcomes 
assessed pre, post, and 3-months later. Qualitative 
interviews also conducted. 
Uptake rate = 5% (10/201); Retention=90% (9/10). 
Significant feasibility concerns. 
34 Grunfeld, 
Hunter & 
Yousaf (2017) 
UK Prostate Cancer 
patients and 
survivors 
N=20 Qualitative / 
Single arm 
feasibility 
study 
(substudy of 
larger RCT) 
n/a Participants from treatment arm completed semi-
structured interviews. Framework analysis – 
intervention was well received, three superordinate 
themes emerged relating to improved symptom 
management; skill acquisition; and broader 
program-benefits.  
35 Alberts, 
Hadijistavropo
ulous, Heather, 
et al. (2017) 
Canada Cancer survivors 
screened for 
distress 
N=18 Single arm 
feasibility trial 
n/a Trialed internet-delivered CBT for recent  survivors. 
Intervention led to reduced depression anxiety, and 
QOL scores. Feasibility demonstrated. 
36 Dozeman, 
Verdonck-de 
Leeuw, Irma, et 
al. (2017) 
Netherlands Breast cancer 
survivors with 
insomnia 
N=171 Single arm 
feasibility trial 
n/a Trialed guided internet-CBT for insomnia with breast 
cancer patients.  Program received high value 
ratings (7.5/10); 59% completed intervention fully;  
feasibility, acceptability and effectiveness (improving 
insomnia severity, fatigue and daytime functioning) 
demonstrated, especially younger or those with 
greater symptom severity at baseline.  
37* McGill, 
Sansom-Daly, 
Wakefield, et 
al. (2017) 
Australia AYA  N=39 Substudy of 
RCT 
n/a Intervention participants from online “Recapture 
Life” program rated therapeutic alliance and group 
cohension – both were highly rated, demonstrating 
feasibility and acceptability of this modality. 
  
38 Zhou, 
Vrooman, 
Manley, et al. 
(2017) 
USA AYA with 
Insomnia 
N=12 Single-arm 
pilot 
n/a Adapted 10-session CBT-insomnia to improve 
accessibility by delivering blended therapy – in-
person (6-sessions) and videoconference (4 
sessions). Intervention immediately improved sleep 
variables, sustained at 2-months. Feasibility 
demonstrated. 
39 Zhou, 
Partridge & 
Recklitis (2017) 
USA Cancer survivors 
with insomnia 
N=38 Single arm 
feasibility trial 
n/a Trialed group CBT-Insomnia (3-session); Significant 
pre-post improvements in sleep efficiency, quality 
and insomnia symptoms. 
Treatment Attrition  = 24%. 
40 Chambers, 
Ritterband, 
Thorndike, et 
al. (2018) 
Australia Cancer patients 
screened for 
distress 
N=163 
(T: 79; 
C: 84) 
RCT Attention 
control (static 
patient 
education 
website) 
RCT of web-based CBT “CancerCope” for 
distressed cancer patients. Intention to treat analysis: 
No impact on primary or secondary outcomes. Per-
protocol analyses: CancerCope significantly greater 
reductions in distress, cancer-specific distress and 
unmet needs at 8-week follow-up compared to 
control. Younger patients more likely to complete 
intervention. 
41** Cheung, Cohn, 
Dunn, et al. 
(2017)  
USA Metastatic breast 
cancer patients 
N=39 
(T1:13; 
T2: 13; 
T3: 13) 
RCT Attention-
control 
Randomized pilot of a positive-affect skill 
intervention (LILAC), comparing face-to-face vs 
online delivery vs attention-control. Feasibility, 
acceptability and retention all demonstrated. 
Within group analyses: LILAC (regardless of delivery) 
reduced depression and negative affect at 1-month 
follow-up. Control participants did not change. 
42 Desautels, 
Savard, Ivers, 
et al. (2018) 
Canada Breast Cancer 
patients with 
depression 
N=62 
(T1:25; 
T2:26; 
C:11) 
RCT Waitlist control Compared 8-week cognitive therapy (T1) vs bright 
light therapy (T2) vs waitlist control for depressed 
breast cancer patients. T1 superior to T2 at post-tx 
on depression scores; both T1 and T2 significantly 
better treatment gains (sustained) cf WLC. 
  
43 Hummel, Van 
Lankveld, 
Jacques, et al. 
(2017) 
Netherlands Breast Cancer 
survivors with 
DSM-IV diagnosis 
of sexual 
dysfunction 
N=169 
(T:84; 
C: 85) 
RCT Waitlist control Compared internet-delivered CBT vs waitlist control 
for sexual functioning.  62% completed CBT. CBT 
significantly greater improvement on range of sexual 
functioning outcomes, body image, menopausal 
symptoms.  CBT=C for orgasmic functioning sexual 
satisfaction, relationship intimacy, marital 
functioning, psych distress and QOL. 
44 Irwin, 
Olmstead, 
Carrillo, et al. 
(2017)  
USA Cancer survivors 
with Insomnia 
N=90 
(T1:45; T2: 
45) 
RCT – 
noninferiority 
Active 
treatment 
(CBT) 
Compared Tai Chi Chih (TCC) to CBT. 
TCC noninferior to CBT.  Insomnia treatment 
response TCC = 46.7% vs CBT = 43.7% @ 15-month 
follow-up; 
45* Lichtenthal, 
Corner, 
Roberts, et al. 
(2017) 
USA Breast cancer 
survivors with 
fear of recurrence  
N=110 
(T1:38 
T2: 36 
C: 36) 
RCT Attention 
control 
Examined feasibility, acceptability, preliminary 
efficacy of 2-versions of home-delivered cognitive 
bias modification intervention vs control.  
Interventions significantly improved health worries 
and interpretation biases. No reductions in fear of 
recurrence. Only 26% uptake rate; but high retention 
(83%) and satisfaction (90%) ratings. 
46 Mendoza, 
Capafons, 
Gralow, et al. 
(2017) 
USA Heterogeneous 
curative cancer 
patients / 
survivors 
N=44 
(T:22; C: 
22) 
RCT - 
crossover 
Education 
control 
(participants 
received both 
conditions in 
counterbalanc
ed order) 
Trial of Valencia model of hypnosis + CBT for pain, 
fatigue & sleep management 
Treatment significantly greater improvements than 
control on all outcomes (pain, fatigue, sleep, 
depression, pain interference, pain catastrophizing, 
cancer-distress), sustained at 3-months. 
  
47 Merckaert, 
Lewis, 
Delvallez, et al. 
(2017) 
Belgium Breast cancer 
patients 
N=159 
(T1:82; 
T2: 77) 
RCT Active 
treatment 
Compared a single-component (support) vs multi-
component (CBT+hypnosis) group intervention for 
anxiety regulation. 
20% uptake rate. Multi-component significantly 
greater reductions in anxiety, heart rate, FCR-
distress; improvements in anxiety regulation, coping 
strategies than single-component. 
48 Peoples, 
Garland, Perlis, 
et al. (2017)  
USA Cancer survivors 
with Insomnia 
N=95 
(T1:24; T2: 
23; 
T3: 24; 
C: 25) 
RCT Placebo Compared CBT-insomnia + placebo (T1); CBT-I + 
armodafinil (T2); Armodafinil (T3); placebo (C) 
CBT significantly improved QOL post-intervention 
with benefits sustained at 3-m; armodafinil had no 
effect on QOL. 
49 Sandler, 
Goldstein, 
Horsfield, et al. 
(2017) 
Australia Cancer survivors 
with fatigue 
N=46 
(T: 23 
C: 23) 
RCT Education 
control 
CBT significantly and clinically greater improvements 
in fatigue and functional status. 
Low response rate. Magnitude of benefit couldn’t be 
determined due to small sample size.  
50* Turner, Kelly, 
Clarke, et al. 
(2017)  
Australia Depressed 
Cancer patients 
N=469 
(T: 247 
C: 222) 
RCT – cluster Stepped-
wedge control 
(usual care) 
Trial of brief 4-session CBT delivered via front-line 
oncology health professionals. Intervention non-
superior to control in anxiety and depression scores. 
Intervention participants with disease progression 
had significantly reduced unmet needs compared to 
control. 
51* van der Wal, 
Thewes, 
Gielissen, et al. 
(2017)  
Netherlands Breast, prostate, 
colorectal cancer 
survivors with 
high fear of 
cancer recurrence 
N=88 
(T: 45; 
C: 43) 
RCT Usual care Trial of blended (face-to-face and online) CBT; 
Blended CBT had statistically and clinically 
significantly lower fear of cancer recurrence than C 
with moderate to large effects. Treatment-attrition 
rate 33%. 
  
52 Willems, 
Bolman, 
Mesters, et al. 
(2017) 
Netherlands Recent cancer 
survivor12 
N=462 
(T:231; 
C: 231) 
RCT Waitlist control Trial of a web-based ‘Cancer Aftercare Guide’. 
Attrition rate=11.5%. At 6-months: Intervention 
significantly greater improvements in depression, 
fatigue, emotional and social functioning vs control. 
Small effects but clinically relevant. 
53 Willems, 
Mesters, 
Lechner, et al. 
(2017) 
Netherlands Recent cancer 
survivors 
N=462 
(T:231; 
C: 231) 
RCT Waitlist control Trial of a web-based ‘Cancer Aftercare Guide’. 
At 12-months: Intervention no longer significantly 
different from control in depression, fatigue, 
emotional or social functioning. Moderator analysis: 
at 6-months male gender, younger age, 
chemotherapy were moderators. At 12-months 
education level moderated.  
54 Willems, 
Lechner, 
Verboon, et al. 
(2017) 
Netherlands Recent cancer 
survivors 
N=462 
(T:231; 
C: 231) 
RCT Waitlist control Secondary analysis of Cancer Aftercare Guide trial, 
to test hypothesized mediators. Intervention effects 
in decreasing depression and fatigue were mediated 
by personal control; problem solving skills did not 
mediate effects.  
55 Wootten, 
Meyer, Abbott, 
et al. (2017) 
Australia Localised 
prostate cancer 
N=142 
(T1:47 
T2:48 
T3:47) 
RCT Active 
treatment 
(Online forum) 
Trial of online CBT intervention (T1), CBT+forum (T2) 
vs forum only (T3). Only T3 led to significant 
improvements in total sexual satisfaction, with large 
effect size. Structural equation modelling showed 
increased sexual function, masculine self-esteem and 
sexual confidence were mediators in the T3 
condition. 
 
  
Table 2. Summary information for third-wave research published since January 2017 
 
Paper 
Ref # 
Authors  
& Date Country Population 
Sample 
Size 
Study 
Design 
Type of 
control group 
Summary 
Outcome 
MINDFULNESS-BASED INTERVENTIONS     
57** Haller, Winkler, 
Klose, et 
al.(2017) 
Germany Breast cancer 10 studies Systematic 
review 
n/a Total sample of 1709 participants in 10 studies 
reported over 14 articles included. Intervention 
effects did not result in clinically meaningful 
differences in outcomes. Post intervention 
improvements in: Qol, fatigue, sleep, stress, anxiety, 
depression. 6 month follow-up: Reduced anxiety and 
depression. 12-month follow-up: reduced anxiety 
Risk of bias was unclear for most items, other than 
attrition & other which were low. When compared to 
other active interventions, significant mindfulness 
effects noted only post-intervention and only for 
anxiety & depression. 
58* Shaw, Sekelja, 
Frasca, et 
al.(2018) 
Australia Mixed cancer 30 studies Systematic 
review 
n/a No studies adhered to formal MBSR program.  
Modifications were poorly justified, contact time 
lower than standard protocols, target outcomes 
poorly justified. 12 did not identify primary aim. 
Few recruited clinical samples, and most that did 
failed to report clinical cut-offs. Overall methodology 
of studies is poor and results unclear. 
59 Carson, 
Carson, Olsen, 
et al. (2017) 
Canada Metastatic breast 
cancer 
N=65 
(T: 40; C: 
20) 
RCT Attention 
control (social 
support) 
Protocol paper reporting design. Assessing 
feasibility and symptoms (pain fatigue, sleep quality, 
psychological distress, mindfulness and functional 
capacity). 
  
60 Ho, Wan, 
Chan, et 
al.(2017) 
Hong Kong Early breast 
cancer 
n/a RCT - protcol Waitlist control Protocol paper reporting design. Assessing cancer-
related symptoms and symptom distress. 
61* Garland, 
Thielking, 
Thomas, et al. 
(2017) 
USA Mixed cancer N=97 Cross-
sectional 
survey 
n/a Dispositional mindfulness and positive reappraisal 
may be pathway by which mindfulness improves 
outcomes. 
62 Liu, Qiu, Louie 
(2017) 
USA Breast cancer N=89 Cross-
sectional 
survey 
n/a 24% used Mindfulness Sitting Medication (MSM) 
intervention. Those who did had better English, 
income, education. Perception of effectiveness MSM 
was variable. Better English predicted MSM use. 
63* Pollard, 
Burchell, 
Castle et al. 
(2017) 
Australia Head and neck 
cancer 
N=19 Single arm 
feasibility trial 
n/a Demonstrated feasibility and acceptability. No 
change in mindfulness scores. Tension anxiety 
reduced but depression did not. 
64 Campo, Bluth, 
Santacroce, et 
al. (2017) 
USA AYA N=34 Single arm 
feasibility trial 
n/a Intervention was feasible. All psychosocial outcomes, 
except for resilience, demonstrated significant 
changes with medium to large effect sizes 
65 Lee, Kim, Kim, 
et al. (2017) 
Korea Metastatic breast 
cancer 
N=18 Single arm n/a No significant change in pain, depression, distress. 
66 Rohanszky, 
Berenyi, 
Fridrik, 
Pusztafalvi 
(2017) 
Hungary Mixed cancer N=173 Cohort study Non-cancer 
control 
Psychological outcomes improved after intervention, 
improvements in two aspects QOL sustained at 6 
months. 
67 Van der Gucht, 
Takano, 
Labarque, et 
al. (2017) 
Belgium AYA N=16 Single arm n/a Reduction in emotional distress and improved QoL 
at 3 months, reduction in negative attitudes toward 
self, and improved mindfulness skills. 
  
68 Black, Peng, 
Sleight, et al. 
(2017) 
USA Colorectal cancer 
receiving 
chemotherapy 
N=57 RCT Attention 
control (cancer 
education) or  
resting 
exposure 
Mindfulness group showed increase in cortisol levels 
at 20 mins during chemotherapy infusion. Cortisol 
levels did not correlate with behavioural outcomes 
measured. 
69 Boyle, Stanton, 
Ganz, et al. 
(2017) 
USA Early breast 
cancer 
N=71 RCT Waitlist control Self-kindness, rumination, increased mindfulness 
mediated reduction in depressive symptoms.  
70 Chambers, 
Occhipinti, 
Foley, et al. 
(2017) 
Australia Prostate cancer N=189 
(T: 94; C: 
95) 
RCT Enhanced 
usual care 
Did not reduce psychological distress, cancer-
specific distress, and PSA anxiety. 
71* Johannsen, 
O'Toole, 
O'Connor, et 
al. (2017) 
Denmark Early breast 
cancer 
N=129 
(T: 67; C: 
62) 
RCT Waitlist control Attachment avoidance was a significant moderator 
and may help identify those who would benefit most 
from MBCT. 
72* Kenne 
Sarenmalm, 
Martensson, 
Andersson, et 
al. (2017) 
Sweden Early breast 
cancer 
N=166 
(T: 62; AC: 
52; 
C: 52) 
RCT Active control 
(self-instructing 
MBSR or  
non-MBSR) 
Mindfulness reduced depressive symptoms, 
symptom burden, and improved mental health.  
Mindfulness did not change anxiety. 
73 Reich, 
Lengacher, 
Alinat, et al. 
(2017) 
USA Early breast 
cancer 
N=322 (T: 
167; C: 
155) 
RCT Usual care Identified symptom cluster: Pain, Psychological, 
Fatigue, Cognitive. At 6 weeks mindfulness reduced 
symptoms but not sustained at 12 weeks. 
74 Reynolds, 
Bissett, Porter, 
Consedine 
(2017). 
New Zealand Early stage 
cancer + having 
chemotherapy 
N=68 
(T: 32; C: 
36) 
RCT Active control 
(relaxation 
training) 
Mindfulness intervention was associated with 
increased symptom distress and social avoidance 
and reduced quality of life. 
  
75* Schellekens, 
Tamagawa, 
Labelle, et al. 
(2017) 
Canada Early breast 
cancer 
N=139 
(T: 69; C: 
70) 
RCT Supportive 
Expressive 
Therapy 
Mood disturbance & Stress symptoms were reduced 
in MBCR group, QOL was not. Social support 
increased T1-2 in MBCR group compared to SET - 
social support is important. 
76 Zhang, Zhou, 
Feng, et al. 
(2017) 
China Breast cancer N=60 RCT Waitlist control MBSR promoted PTG and decreased perceived 
stress and anxiety. 
ACCEPTANCE AND COMMITMENT THERAPY     
77* Cederbeg, 
Dahl, von 
Essen, et al. 
(2017) 
Sweden Paediatric (4-18 
years of age) 
N=5 Single-
subject 
research 
design 
n/a All five participants reported decreased discomfort 
of pain and improved pain-related coping. Three out 
of five reported lower pain intensity. 
78* Aguirre-
Camacho, 
Pelletier, 
González‐
Márquez, et al. 
(2017) 
Spain Breast cancer 
survivors 
N=54 Single-arm n/a Changes in anxiety and depression across the 
intervention were predicted by changes in 
experiential avoidance. The pathway from 
experiential avoidance to quality of life was indirect, 
operating via the depression pathway. Path analyses 
showed good fit indices. 
79** González-
Fernández, 
Fernández-
Rodríguez, 
Paz-Caballero 
(2017) 
Spain Disease free 
cancer survivors, 
screened for high 
distress 
N=66 
(T1:17; AC: 
22; C:27) 
RCT Active control 
(Behavioural 
Activation) and 
wait-list 
control.  
Both treatment groups were superior to control in 
reducing anxiety, depression: similar patterns of 
change in experiential avoidance indicates a 
potential mediator of intervention affect in both 
groups. 
80* Mosher, 
Secinti, Li, et 
al. (2018) 
USA Metastic breast 
cancer 
N=47 
(T:23; C:24) 
Pilot RCT Education / 
Support Group 
Feasibility was demonstrated for a future trial. 
Although between group differences were not 
significant, greater reductions in sleep-related 
symptom interference and impairment were 
reported in the treatment group. 
  
81** Urech, 
Grossert, 
Alder, et al. 
(2018) 
Switzerland, 
Germany, 
Austria, UK 
Newly diagnosed 
cancer patients 
(within 12 weeks 
of treatment 
start) 
N=129 
(T:65; C:64) 
RCT Wait-list 
control 
Quality of life and distress improved in the 
intervention group significantly more than controls 
(small-medium effect sizes). Between-group 
comparison in anxiety and depression were not 
significant. Quality of life improvement was 
observed in the control group after delayed access 
to the intervention.  
82** Montesinos & 
Luciano (2016) 
Spain Breast cancer 
survivors 
N=12 
(T: 8; C:4) 
Non-
randomised, 
open trial 
Wait-list 
control 
Statistically significant reductions in interference 
related to, and intensity of, fear of recurrence. Large 
effect sizes maintained to three month follow up. 
Distress, anxious preoccupation and hypochondria 
decreased but not significantly between groups. 
83 Mosher, 
Tometich, 
Hirsh, et al. 
(2017) 
USA Metastatic breast 
cancer 
N=80 Observationa
l / survey 
study 
n/a Cluster analysis methods were used to determine 
three groups of symptom experience (low, low-
moderate, moderate-high). Between-group 
differences were found in psychological inflexibility 
and value obstruction, but not value progress. 
84 Davis, Deane, 
Lyons, Barclay 
(2017) 
Australia Palliative patients N=73 Observationa
l / survey 
study 
n/a Strong correlations between acceptance and 
anxiety, depression and anticipatory grief. 
Regression models determined that acceptance 
predicted 13% variance above anxiety and 
depression for anticipatory grief. 
85* Swash, 
Bramwell, 
Hulbert-
Williams (2017) 
UK Haematological 
cancer survivors, 
<18 months post-
diagnosis 
N=91 Observationa
l / survey 
study 
n/a Psychological flexibility correlated with unmet 
psychosocial supportive care needs, anxiety, 
depression and quality of life. Regression models 
testing moderating effects of psychological flexibility 
between needs and anxiety, depression and quality 
of life were significant in 4/15 cases. 
  
META-COGNITIVE THERAPY 
86** Butow, Turner, 
Gilchrist, et al. 
(2017) 
Australia Breast, 
colorectal, 
melanoma cancer 
survivors 
screened for 
clinical fear of 
cancer recurrence 
N=222 
(T:121  
C: 101) 
RCT Relaxation 
control (active 
control) 
RCT of ‘Conquer Fear’, a therapist-administered 
therapy for reducing fear of cancer recurrence (FCR). 
Treatment superior to control for clinically and 
statistically reducing FCR total score and severity 
subscales, general anxiety, cancer-specific distress, 
mental QOL and meta-cognitions. Benefits sustained 
at 3- and 6-month follow-up for FCR total score. 
87* Fisher, Byrne, 
Salmon (2017) 
UK Cancer survivors 
attending an 
adult clinical 
psychology 
cancer service 
N=4 Single-
subject 
research 
design 
n/a Clinically-significant reductions in anxiety, 
depression and fear of cancer recurrence were 
observed in all cases. Effects were maintained at six-
month follow-up in 3/4 participants. 
 
  
Table 3. Summary information for other intervention research published since January 2017 
 
Paper 
Ref # 
Authors  
& Date Country Population 
Sample 
Size 
Study 
Design 
Type of 
control group 
Summary 
Outcome 
SUPPORT GROUPS, SUPPORTIVE EXPRESSIVE THERAPY AND COUNSELLING 
95** McCaughan, 
Parahoo, 
Hueter, et al. 
(2017) 
International Breast cancer 6 studies Systematic 
Review 
n/a Total sample of 492 participants included. Quality of 
trials was low. Mixed results for both anxiety & 
depression. Unclear whether participation in online 
support groups is beneficial. 
96 Banks, Pearce, 
French, et al. 
(2017)  
UK Adult cancer 
patients or 
caregivers 
N=158 Single arm n/a Psychological distress improved in both patients and 
caregivers Counselling outside healthcare setting is 
beneficial to both patients and caregivers. 
97 Bober, 
Recklitis, 
Michaud, 
Wright (2018) 
USA Ovarian cancer N=53 Cohort study n/a Sexual function improved over time;  Psychological 
distress improved. Participants were satisfied with 
intervention. 
98 Carlson, 
Rouleau, 
Speca, et al. 
(2017)  
Canada Partners of men 
with prostate 
cancer (but 
outcomes 
collected on 
patients too) 
N=77 
(T: 45; C: 
32) 
RCT Usual care No differences between SET and US groups at all at 
any time point. Partners in both groups reported 
improvement in mood, tension, anger, confusion, 
state anxiety and emotional support. 
99 Kim, 
Scheufele, 
Han, Shah 
(2017) 
USA Breast cancer N=221 RCT – 
secondary 
analysis 
n/a Opinion leadership positively related to cancer 
information competence and breast cancer 
knowledge. Those giving more advice employed 
more active coping strategies. No impact on HQOL. 
No difference on personality traits. Opinion leaders 
more likely to be optimistic. 
  
100 Stephen, 
Rojubally, 
Linden, et al. 
(2017)  
Canada Young breast 
cancer aged <50 
years 
N=96 RCT Active control 
(self-help 
psycho-
education and 
workbook 
Small reduction in illness intrusiveness and 
depressive symptoms for online support group. 
Control group demonstrated greater improvement 
in post-traumatic growth. 
101 Dorros, Segrin 
Badger (2017)  
USA Early breast 
cancer, prostate 
cancer 
N=86 Cohort study n/a Survivor concerns were cancer- and treatment-
related issues. Partner concerns were the well-being 
of their spouse with cancer, and their role in helping 
cope with illness. Key concerns were relationship 
maintenance and communication issues. 
102 Mareschal, 
Weber, Rigoli, 
et al. (2017)  
Switzerland Early prostate 
cancer 
N=35 Single arm n/a Cognitive function did not decline significantly, 
anxious and depressive symptoms remained below 
clinically significant thresholds. Pattern of symptoms 
& side effects differed from that expected in patients 
on AD+RT 
103* Manne, Virtue, 
Ozga, et al. 
(2017) 
USA Gynaecological 
cancers 
N=352 RCT Usual care CCI participants greater decline in depression and 
cancer-related distress at 6 months only. SC 
outcomes did not differ from UC 
104* Scarpa, Pinto, 
Saraceni, et al. 
(2017) 
Italy Oesophageal 
cancer 
N=87 RCT Usual care Psychological counselling improved HQOL and 
sleep outcomes, reduced use of hypnotic 
medications. Did not change pain scores. 
105 Faller, Weis, 
Koch, et al. 
(2017) 
Germany Mixed cancer N=4020 Cross-
sectional 
survey 
n/a 28.9% accessed PT (13.4%) or PC (24.2%) for cancer 
related concerns. Less than half diagnosed with 
mental disorder reported uptake of therapy. Use was 
lowest in acute care hospitals (22.1%.) 32.1% 
reported current need and of those 54.4% had 
previously accessed care. Young, women, high 
education all reported higher use 
  
106 Matsui, 
Tanimukai 
(2017) 
Japan Early breast 
cancer 
N=171 Cross-
sectional 
survey 
n/a 51% had used a psychosocial support service.  
40% were members of a survivorship organization 
and were more likely to use support services. Of the 
515 reporting use of services, 46% had accessed 
more than 1. 
107 Huber, Maatz,  
Muck T, et al. 
(2017) 
Germany Prostate cancer N=668 Cross-
sectional 
survey 
n/a 200 men revised treatment decision after exposure 
to decision aid. They were more likely to opt for 
external beam RT or active surveillance than radical 
prostatectomy. Engaging longer with OSG, more 
active role in decision-making, being in conventional 
support group independently associated with 
revised decision. 
108 Wang, Zhao, 
Street (2017)  
USA Breast cancer n/a Content 
analysis of 
Online Health 
community 
(OHC) 
n/a 2.8 million posts by approx. 50,000 users, most were 
not very active. Users who provided more 
informational support, sought more emotional 
support or posted more about companionship had 
longer time spans of activities in the OHC; 
Those who sought or received more informational 
support often left the OHC earlier. 
109 Beatty, 
Binnion, Kemp, 
Koczwara 
(2017)  
Australia Cancer - mixed N=13 Qualitative n/a 19 individual barriers identified: Most disease 
related followed by intervention factors, 
computer/tech, psychological, personal factors. 17 
facilitators, intervention most prevalent, 
psychological, computer/tech, and personal factors 
110 Hammer, 
Egestad, 
Nielsen, et al. 
(2017) 
Denmark Early cancer - 
mixed 
N=17 Pilot n/a Participants motivated to engage in reading fiction 
again. The group was important, especially face to 
face. Did not like literary selection but found regular 
walking rewarding. Most were not clinically 
depressed or anxious, but had sleep disturbance 
and did light PA. 
  
111 Melton, 
Brewer, Kolva, 
et al. (2017) 
USA Young Adults N=8 Pilot n/a Excellent retention, adherence varied but generally 
high for each session. Telemedicine enabled 
participation in groups despite being hospitalised or 
unwell. Participants were comfortable using 
technology, none wanted to attend in person, all 
reported increased sense of connection. 
DIGNITY AND NARRATIVE THERAPY 
112** Martínez, 
Arantzamendi, 
Belar et al. 
(2017) 
Spain Palliative care 28 studies Systematic 
Review 
n/a Five RCTs were included; only two showed 
significant effects on anxiety and depression. 
Nonrandomised studies also show statistical 
improvements, and interventions were typically 
rated positively and beneficial for end-of-life 
experience. 
113 Ho, Car, Ho, et 
al. (2017)  
Singapore Palliative care n/a RCT - 
Protocol 
Usual care This paper presents a protocol for a novel culturally 
adapted, couples-based Dignity Therapy RCT 
currently underway in Singapore. 
114 Dose & Rhudy 
(2018) 
USA Advanced 
cancer, 
undergoing 
chemotherapy 
N=20 Qualitative   n/a Presentation a thematic analysis of experiences of a 
group of patients undergoing Dignity Therapy.  
Emphasised the importance of talking about family 
and of imparting a message of hope. 
115 Vuksanovic, 
Green, 
Morrissey, 
Smith (2017). 
Australia Advanced 
terminal disease 
N=70 
(T: 23; 
AC: 23; 
C:24) 
 
Qualitative 
(substudy of 
larger RCT) 
Life Review 
and Waitlist 
control 
This qualitative analysis of legacy documents (from 
Dignity Therapy arm) and Life Review session 
transcripts were analysed using Framework analysis. 
Dignity therapy resulted in qualitatively difference 
session content, even controlling for therapist 
influences and session length. 
116* Dose, 
Hubbard, 
Mansfield, et 
al. (2017) 
USA Advanced 
pancreatic or 
non-small cell 
lung cancer 
N=18 Single-arm 
feasibility trial 
n/a Feasibility and acceptability were demonstrated. 
Participants completing the intervention reported 
that their expectations were met or exceeded and 
that they would recommend it to others.  
  
117** Julião. 
Oliveira, 
Nunes, et al. 
(2017) 
Portugal Life-threatening 
illness with 
prognosis 
<6months 
N=80  
(T:41; C:39) 
RCT Usual care Dignity Therapy resulted in significantly decreased 
demoralisation and desire for death. Significantly 
greater improvement on 19/25 items of the Patient 
Dignity Inventory. 
118* Vuksanovic D, 
Green H, Dyck 
M & Morrissey 
S (2017) 
Australia Advanced 
terminal disease 
N=70 
(T: 23; 
AC: 23; 
C:24) 
 
RCT Life Review 
and Waitlist 
control 
Significant increases were reported in generatively 
and ego-integrity in the Dignity Therapy group only. 
Despite high levels of acceptability and intervention 
satisfaction, no significant changes in dignity-related 
distress, or QOL were reported in any trial arm. 
119* Lloyd-Williams, 
Shiels, Ellis, et 
al. (2018) 
UK Palliative care N=57 
(T: 33; C: 
24) 
Pilot RCT Usual care Feasibility was demonstrated: although a non-
significant between-group difference, greater 
improvement in distress and longer median survival 
were observed in the intervention group. 
120** Wise, 
Marchand, 
Roberts, Chih 
(2018).  
USA Stage III or IV 
cancer patients  
N=86 RCT Active control There were no significant effects at two month 
follow-up, but by 4-months, the intervention group 
reported a significantly greater increase in peace. 
There were no significant effects on meaning, 
depressed, anxious or angry mood. 
COACHING-BASED APPROACHES   
121** Yun, Kim, Lee, 
et al. (2017) 
South Korea Mixed cancer 
survivors 
N=248 
(T: 166; C: 
82) 
RCT Usual care Significantly greater improvement in the intervention 
group on anxiety (but not depression) and some 
aspects of quality of life between baseline and three 
month follow-up. Only the fatigue component of 
quality of life was significant in baseline to one year 
follow-up analysis. 
122* McCusker, 
Yaffe, Faria, et 
al. (2018) 
Canada Mixed cancer 
survivors 
N=32 Single-arm n/a Good recruitment and retention rates were 
demonstrated and along with significant 
improvements in key outcomes, this demonstrates 
potential feasibility and acceptabilty for a larger trial. 
 
